Exact Mass: 428.2423

Exact Mass Matches: 428.2423

Found 99 metabolites which its exact mass value is equals to given mass value 428.2423, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Irbesartan

2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one

C25H28N6O (428.2324)


Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2774 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

   
   

Lotrafiban

2-(7-{[4,4-bipiperidine]-1-carbonyl}-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl)acetic acid

C23H32N4O4 (428.2423)


   

Dendronpholide I

Dendronpholide I

C22H36O8 (428.241)


   

Rhodomollein XI

Rhodomollein XI

C22H36O8 (428.241)


   

Rhodomollein XVI

Rhodomollein XVI

C22H36O8 (428.241)


   

Dendronpholide J

Dendronpholide J

C22H36O8 (428.241)


   

Lyoniol D|Lyoniol-D

Lyoniol D|Lyoniol-D

C22H36O8 (428.241)


   

Echinoclathrine C

Echinoclathrine C

C25H36N2O2S (428.2497)


   

3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-

3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-

C22H36O8 (428.241)


   

13,14-dihydroxy-15,16 dimethoxy-(-)-6alpha-hydroxy-5alpha,8alpha,9alpha,10alpha-cleroda-3-en-18-oic acid

13,14-dihydroxy-15,16 dimethoxy-(-)-6alpha-hydroxy-5alpha,8alpha,9alpha,10alpha-cleroda-3-en-18-oic acid

C22H36O8 (428.241)


   

5beta,11-dihydroxy-iphionan-4-one-11-O-(alpha-xylopyranoside-2-O-acetate)|5beta,11-dihydroxy-iphionan-4-one-11-O-

5beta,11-dihydroxy-iphionan-4-one-11-O-(alpha-xylopyranoside-2-O-acetate)|5beta,11-dihydroxy-iphionan-4-one-11-O-

C22H36O8 (428.241)


   

4,5-dioxo-seco-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|4,5-dioxo-seco-gamma-eudesmol-

4,5-dioxo-seco-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|4,5-dioxo-seco-gamma-eudesmol-

C22H36O8 (428.241)


   
   
   

irbesartan

irbesartan

C25H28N6O (428.2324)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1074 CONFIDENCE standard compound; INTERNAL_ID 2094 CONFIDENCE standard compound; INTERNAL_ID 8187 Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

   

Irbesartan (Avapro)

Irbesartan (Avapro)

C25H28N6O (428.2324)


Irbesartan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=138402-11-6 (retrieved 2024-07-09) (CAS RN: 138402-11-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

   

Ala Lys Asn Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Ala Lys Pro Asn

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H32N6O6 (428.2383)


   

Ala Asn Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Ala Asn Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C18H32N6O6 (428.2383)


   

Ala Pro Lys Asn

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-carbamoylpropanoic acid

C18H32N6O6 (428.2383)


   

Ala Pro Asn Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]hexanoic acid

C18H32N6O6 (428.2383)


   

Gly Lys Pro Gln

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-(2-aminoacetamido)hexanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H32N6O6 (428.2383)


   

Gly Lys Gln Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Gly Pro Lys Gln

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}hexanamido]-4-carbamoylbutanoic acid

C18H32N6O6 (428.2383)


   

Gly Pro Gln Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]hexanoic acid

C18H32N6O6 (428.2383)


   

Gly Gln Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Gly Gln Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C18H32N6O6 (428.2383)


   

Lys Ala Asn Pro

(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Lys Ala Pro Asn

(2S)-3-carbamoyl-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H32N6O6 (428.2383)


   

Lys Gly Pro Gln

(2S)-4-carbamoyl-2-{[(2S)-1-{2-[(2S)-2,6-diaminohexanamido]acetyl}pyrrolidin-2-yl]formamido}butanoic acid

C18H32N6O6 (428.2383)


   

Lys Gly Gln Pro

(2S)-1-[(2S)-4-carbamoyl-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}butanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Lys Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Lys Asn Pro Ala

(2S)-2-{[(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H32N6O6 (428.2383)


   

Lys Pro Ala Asn

(2S)-3-carbamoyl-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C18H32N6O6 (428.2383)


   

Lys Pro Gly Gln

(2S)-4-carbamoyl-2-(2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}acetamido)butanoic acid

C18H32N6O6 (428.2383)


   

Lys Pro Asn Ala

(2S)-2-[(2S)-3-carbamoyl-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C18H32N6O6 (428.2383)


   

Lys Pro Gln Gly

2-[(2S)-4-carbamoyl-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}butanamido]acetic acid

C18H32N6O6 (428.2383)


   

Lys Gln Gly Pro

(2S)-1-{2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Lys Gln Pro Gly

2-{[(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H32N6O6 (428.2383)


   

Asn Ala Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Asn Ala Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C18H32N6O6 (428.2383)


   

Asn Lys Ala Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Asn Lys Pro Ala

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H32N6O6 (428.2383)


   

Asn Pro Ala Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]hexanoic acid

C18H32N6O6 (428.2383)


   

Asn Pro Lys Ala

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}hexanamido]propanoic acid

C18H32N6O6 (428.2383)


   

Pro Ala Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]-3-carbamoylpropanoic acid

C18H32N6O6 (428.2383)


   

Pro Ala Asn Lys

(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]hexanoic acid

C18H32N6O6 (428.2383)


   

Pro Gly Lys Gln

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}hexanamido]-4-carbamoylbutanoic acid

C18H32N6O6 (428.2383)


   

Pro Gly Gln Lys

(2S)-6-amino-2-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]hexanoic acid

C18H32N6O6 (428.2383)


   

Pro Lys Ala Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]propanamido]-3-carbamoylpropanoic acid

C18H32N6O6 (428.2383)


   

Pro Lys Gly Gln

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]acetamido}-4-carbamoylbutanoic acid

C18H32N6O6 (428.2383)


   

Pro Lys Asn Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-carbamoylpropanamido]propanoic acid

C18H32N6O6 (428.2383)


   

Pro Lys Gln Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-carbamoylbutanamido]acetic acid

C18H32N6O6 (428.2383)


   

Pro Asn Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]hexanoic acid

C18H32N6O6 (428.2383)


   

Pro Asn Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]propanoic acid

C18H32N6O6 (428.2383)


   

Pro Gln Gly Lys

(2S)-6-amino-2-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}hexanoic acid

C18H32N6O6 (428.2383)


   

Pro Gln Lys Gly

2-[(2S)-6-amino-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanamido]acetic acid

C18H32N6O6 (428.2383)


   

Gln Gly Lys Pro

(2S)-1-[(2S)-6-amino-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}hexanoyl]pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Gln Gly Pro Lys

(2S)-6-amino-2-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]formamido}hexanoic acid

C18H32N6O6 (428.2383)


   

Gln Lys Gly Pro

(2S)-1-{2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H32N6O6 (428.2383)


   

Gln Lys Pro Gly

2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H32N6O6 (428.2383)


   

Gln Pro Gly Lys

(2S)-6-amino-2-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)hexanoic acid

C18H32N6O6 (428.2383)


   

Gln Pro Lys Gly

2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}hexanamido]acetic acid

C18H32N6O6 (428.2383)


   

ZK118182 isopropyl ester

[[4-[5R-chloro-2Z-[3R-cyclohexyl-3S-hydroxy-1R-propenyl]-3S-hydroxycyclopentyl]-2R-butenyl]oxy]-acetic acid, isopropyl ester

C23H37ClO5 (428.2329)


   

HEXOCYCLIUM METHYLSULFATE

HEXOCYCLIUM METHYLSULFATE

C21H36N2O5S (428.2345)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   
   

(3R,4R,5S)-ethyl 4-acetamido-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

(3R,4R,5S)-ethyl 4-acetamido-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

C22H37ClN2O4 (428.2442)


   

2-Phenyl-1-[4-(2-piperidin-1-YL-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-OL

2-Phenyl-1-[4-(2-piperidin-1-YL-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-OL

C28H32N2O2 (428.2464)


   

3-[[cyclopentyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-8-methyl-1H-quinolin-2-one

3-[[cyclopentyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-8-methyl-1H-quinolin-2-one

C25H28N6O (428.2324)


   

(1R)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

(1R)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

C23H32N4O4 (428.2423)


   

(1S)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

(1S)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

C23H32N4O4 (428.2423)


   

ST 22:1;O8

ST 22:1;O8

C22H36O8 (428.241)


   

(2s,3r,4s,5r)-4,5-dihydroxy-2-({2-[(1r,4r)-4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate

(2s,3r,4s,5r)-4,5-dihydroxy-2-({2-[(1r,4r)-4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate

C22H36O8 (428.241)


   

2-{[2-(3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

2-{[2-(3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)


   

(1r,3s,4r,6s,7s,8s,9s,10r,13s,14s,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(1r,3s,4r,6s,7s,8s,9s,10r,13s,14s,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)


   

(2s,3r,4s,5r)-2-({2-[(3r,3ar,5r,7as)-3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

(2s,3r,4s,5r)-2-({2-[(3r,3ar,5r,7as)-3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)


   

4,5-dihydroxy-2-({2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate

4,5-dihydroxy-2-({2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate

C22H36O8 (428.241)


   

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)


   

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

C22H36O8 (428.241)


   

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)


   

(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-2,4,6,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-2,4,6,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)


   

(1r,3r,4r,10s,14r,15r,17r,18s)-18-[(acetyloxy)methyl]-17-hydroxy-3-(methoxycarbonyl)-14-methyl-12λ⁵-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icosa-7(20),12(19)-dien-12-ylium

(1r,3r,4r,10s,14r,15r,17r,18s)-18-[(acetyloxy)methyl]-17-hydroxy-3-(methoxycarbonyl)-14-methyl-12λ⁵-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icosa-7(20),12(19)-dien-12-ylium

[C25H34NO5]+ (428.2437)


   

(1s,13r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(1s,13r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)


   

n-[2-hydroxy-6-(2-methylpyridin-4-yl)phenyl]-13-sulfanyltridecanimidic acid

n-[2-hydroxy-6-(2-methylpyridin-4-yl)phenyl]-13-sulfanyltridecanimidic acid

C25H36N2O2S (428.2497)


   

2-[(1s,2r,5r,7s,8s,11s,12r)-7-(acetyloxy)-2,8,11-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

2-[(1s,2r,5r,7s,8s,11s,12r)-7-(acetyloxy)-2,8,11-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)


   

2-[(1s,2r,5r,7s,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

2-[(1s,2r,5r,7s,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)


   

(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)


   

4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)


   

(2s,3r,4s,5r)-2-({2-[(3s,3as,5r,7as)-3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

(2s,3r,4s,5r)-2-({2-[(3s,3as,5r,7as)-3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)


   

2-{[2-(3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

2-{[2-(3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)


   

(2s,3r,4r,4as,7r,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (4s)-4-hydroxyoctanoate

(2s,3r,4r,4as,7r,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (4s)-4-hydroxyoctanoate

C22H36O8 (428.241)


   

(1r,2s,3s,4r,8r,9s,10r)-2,8,9-trihydroxy-6-oxo-4-pentyl-5,11-dioxabicyclo[8.1.0]undecan-3-yl (2e)-2,4-dimethylhex-2-enoate

(1r,2s,3s,4r,8r,9s,10r)-2,8,9-trihydroxy-6-oxo-4-pentyl-5,11-dioxabicyclo[8.1.0]undecan-3-yl (2e)-2,4-dimethylhex-2-enoate

C22H36O8 (428.241)


   

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

C22H36O8 (428.241)


   

(5s,6r,8s,8ar)-5-{2-[(2s,4s,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-8-hydroxy-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(5s,6r,8s,8ar)-5-{2-[(2s,4s,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-8-hydroxy-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C22H36O8 (428.241)


   

3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

C22H36O8 (428.241)


   

2-[(1s,2r,5r,7r,8s,11s,12r)-7-(acetyloxy)-2,8,11-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

2-[(1s,2r,5r,7r,8s,11s,12r)-7-(acetyloxy)-2,8,11-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)


   

2-[(1s,2r,5r,7r,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

2-[(1s,2r,5r,7r,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)